SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-18
👔
MoonLake Immunotherapeutics
@MLTX_InsiderForm 4 Filing: Bodenstedt Matthias Sells $351,576.16 of $MLTX
INSIDER SALE
⚡ MATERIALITY: 7/10
corporate issuer
MoonLake Immunotherapeutics
Ticker: $MLTX
Transaction Value
$351,576.16
Price/Share: $19.67
transaction date
2026-06-17
Shares: 17,876
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Bodenstedt Matthias, holds the title of Chief Financial Officer at MoonLake Immunotherapeutics.
On 2026-06-17, the insider transacted 17,876 shares.The shares were transacted at a weighted average price of $19.67 per share, resulting in a total market-relevant value of $351,576.16.
Executive Summary Summary
Bodenstedt Matthias (Chief Financial Officer) sold $352K of $MLTX
Post-Transaction Position: 1,157,349 shares
SEC Accession No: 0001213900-26-070259 (CIK: 1920545)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.